Glenmark Pharmaceuticals Inc., USA Recall: Rizatriptan Benzoate Orally Disintegrating Tabl
Glenmark Pharmaceuticals Inc., USA Recall: Rizatriptan Benzoate Orally Disintegrating Tabl is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Glenmark Pharmaceuticals Inc., USA; Product: Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10mg, 18 (3 x 6) Unit-Dose Tablets, Manufactur
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
|---|---|
| Product | Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-468-06 |
| Reason for recall | CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | US Nationwide. |
| Recall initiated | 20240513 |
| Recall number | D-0535-2024 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →